Neuritek Therapeutics secures a capital commitment of 25 million euros from Gem Group

  • Published Month : Tuesday, 31 Mar 2020 03:00 pm

Neuritek Therapeutics secures a € 25m capital commitment from Gem Group to develop next-generation treatments for post-traumatic stress disorder (PTSD)

Neuritek Therapeutics, Ltd. (Neuritek), a biotechnology company incorporated under the laws of the UK and whose principal place of business is located at 200 W 57 th Street, New York, NY 10019 (United States), has announced that it has signed an agreement with the GEM Global Yield LLC SCS ("GEM") group, an alternative private investment group based in Luxembourg, to inject into Neuritek up to 25 million euros in a term of 3 years according to the public listing of Neuritek's ordinary shares. Neuritek will use those funds to develop treatments for Post-Traumatic Stress Disorder (PTSD), a medical condition that often develops in people who have been exposed to severe trauma.

The first 25 million euros will be in the form of a capital commitment that will allow Neuritek to withdraw funds for 3 years by issuing shares in the ordinary market in the name of GEM (or that of the indicated persons) and subject to the loan agreement (s). of actions.

Neuritek will control the terms and the maximum amount of the draft under these conditions and does not have a minimum amount stipulated. In conjunction with the public listing of Neuritek shares, the company will issue warrants to GEM to acquire up to ten percent (10%) of the company's remaining equity securities on a fully diluted basis. Warrants will have an exercise price per share equivalent to the closing price of the shares on the first day of commercial activity after the public offering of shares.

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

A PHP Error was encountered

Severity: Warning

Message: count(): Parameter must be an array or an object that implements Countable

Filename: amp/news_details_amp.php

Line Number: 252

Backtrace:

File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler

File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view

File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once

Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

media@smartmarketnews.com | sales@smartmarketnews.com

Contact Us
Visit Our Sites
© The News and Media Division of The Insight Partners 2019 | All Rights Reserved | Privacy Policy